Julia W. Gargano - Concepedia

Author

Julia W. Gargano

Centers for Disease Control and Prevention ORCID

Also Known As

J GARGANO, J Gargano, J. GARGANO, J. Gargano, J. W. GARGANO, J. W. Gargano, Julia Gargano, Julia W Gargano, Julia W. Gargano, Julia Warner Gargano

106

Publications

9.3K

Citations

H-Index

112

Concepts

All Affiliations

Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases National Center for Immunization and Respiratory Diseases Epidemic Intelligence Service Michigan State University

About

Julia W. Gargano is an author at Centers for Disease Control and Prevention specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.6K
2	Public Health	16	17	1K
3	Engineering	1	1	40
4	Health Sciences	1	1	491
5	Diabetes	1	1	29

Julia W. Gargano

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 Julia W. Gargano, Megan Wallace, Stephen C. Hadler, MMWR Morbidity and Mortality Weekly Report	2021	593
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020 Sara E. Oliver, Julia W. Gargano, Mona Marin, MMWR Morbidity and Mortality Weekly Report	2020	558
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018 Kristen Kreisel, Ian H. Spicknall, Julia W. Gargano, Sexually Transmitted Diseases	2021	526
Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in Julia W. Gargano, I. G. Martin, Poonam Bhandari, Experimental Gerontology Gait AnalysisAge-related Locomotor DeclinePhysical ActivityKinesiologyAging	2005	491
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020 Sara E. Oliver, Julia W. Gargano, Mona Marin, MMWR Morbidity and Mortality Weekly Report	2020	330
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States Sarah A. Collier, Li Deng, E. A. Adam, Emerging infectious diseases	2020	301
Sex Differences in Stroke Recovery and Stroke-Specific Quality of Life Julia W. Gargano, Mathew J. Reeves Stroke	2007	255
Surveillance for Waterborne Disease Outbreaks Associated with Drinking Water — United States, 2011–2012 Karlyn D. Beer, Julia W. Gargano, Virginia A. Roberts, MMWR Morbidity and Mortality Weekly Report Source Water ProtectionInfectious Disease EpidemiologySanitationDrinking Water SystemsWater Contamination	2015	242
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021 Jessica R. MacNeil, John R. Su, Karen R. Broder, MMWR Morbidity and Mortality Weekly Report	2021	182
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 Sara E. Oliver, Julia W. Gargano, Heather M. Scobie, MMWR Morbidity and Mortality Weekly Report VaccinationVaccine SafetyVaccinologyPreventive MedicineVaccine Development	2021	167

Page 1